Morepen Laboratories Ltd. specializes in Pharmaceuticals within the Healthcare sector.
Morepen Laboratories Ltd., with Security Code 500288, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
Date Begin | Date End | Net Sales | Net Profit | Total Income | Diluted EPS for continuing operation | Other Expenses | Other Income | Depreciation and amortisation expense | Profit (+)/ Loss (-) from Ordinary Activities before Tax |
---|---|---|---|---|---|---|---|---|---|
2024-01-01 | 2024-03-31 | 4,230.74 | 282.81 | 4,273.17 | 0.54 | -348.68 | 42.43 | -96.24 | 422.02 |
2023-10-01 | 2023-12-31 | 3,946.33 | 352.02 | 3,982.91 | 0.69 | -270.21 | 36.58 | -55.08 | 472.23 |
2023-10-01 | 2023-12-31 | 4,445.54 | 319.90 | 4,486.25 | 0.63 | -292.36 | 40.71 | -84.45 | 440.20 |
2023-07-01 | 2023-09-30 | 3,812.58 | 199.24 | 3,840.95 | 0.39 | -265.67 | 28.38 | -48.11 | 273.34 |
Compounded Sales Growth | |
---|---|
10 Years: | 16% |
5 Years: | 16% |
3 Years: | 11% |
TTM: | 15% |
Compounded Profit Growth | |
---|---|
10 Years: | 30% |
5 Years: | 31% |
3 Years: | 6% |
TTM: | 140% |
Stock Price CAGR | |
---|---|
10 Years: | 27% |
5 Years: | 26% |
3 Years: | -3% |
1 Year: | 90% |
Compounded Sales Growth | |
---|---|
10 Years: | 17% |
5 Years: | 17% |
3 Years: | 12% |
TTM: | 19% |
Compounded Profit Growth | |
---|---|
10 Years: | 34% |
5 Years: | 27% |
3 Years: | 0% |
TTM: | 149% |
Stock Price CAGR | |
---|---|
10 Years: | 27% |
5 Years: | 26% |
3 Years: | -3% |
1 Year: | 90% |